The role of melatonin treatment in chronic kidney disease.

Marije Russcher, Birgit C. P. Koch, J. Elsbeth Nagtegaal, Karien van der Putten, Pietter Wee, Carlo Gaillard

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)

Abstract

The pineal hormone melatonin plays a major role in circadian sleep-wake rhythm. Patients with Chronic Kidney Disease (CKD), especially those who are on hemodialysis, frequently suffer from sleep disturbances. In this review an overview is given of the classification of stages of chronic kidney disease, followed by a presentation of the circadian rhythm disorders in renal disease involving sleep disturbances in relation to melatonin deficiency. The therapeutic benefit of melatonin treatment in sleep disorders related to chronic kidney disease including the controlled trials solving this topic, is described. Furthermore, the beneficial effect of melatonin on blood pressure alterations in CKD states and the protection of melatonin in oxidative stress and inflammation in renal disorders are explored. Finally a hypothetic model is described for the relation between circadian rhythm disorders and CKD.

Original languageEnglish
Pages (from-to)2644-2656
Number of pages13
JournalFrontiers in Bioscience-Landmark
Volume17
Issue number7
DOIs
Publication statusPublished - 1 Jun 2012
Externally publishedYes

Keywords

  • 24-hour blood pressure
  • Chronic kidney disease
  • Hemodialysis
  • Melatonin
  • Oxidative stress
  • Review
  • Sleep disturbances

Fingerprint

Dive into the research topics of 'The role of melatonin treatment in chronic kidney disease.'. Together they form a unique fingerprint.

Cite this